Week 13: The Room Just Got Quieter — What Modified Peer Review Means for Everything You Just Learned

For twelve weeks, I have been teaching you to hear the room.

How reviewers write. How the discussion reshapes what they wrote. How to find the sentence in the Resume and Summary of Discussion where the room's concern crystallizes. How to build your Introduction page around that sentence rather than around a list of individual critique points.

All of it assumes a room that deliberates. A summary statement that narrates. A process that gives you enough interpretive scaffolding to distinguish what individual reviewers thought from what the panel actually concluded.

But what happens when that scaffolding gets thinner?

In April, NIH extended its modified peer review procedures into the October 2026 Advisory Council cycle - NOT-OD-26-069. Fewer applications discussed. New designations for those that are not. Simplified summary statements with bullets instead of narrative paragraphs. If you read the notice when it came out, you understood the procedural changes. But now - twelve weeks into this series - you can see what those changes actually mean for how you read your next summary statement and how you write your next resubmission.

The framework does not break. It becomes more necessary.

What the modifications actually are

Three changes remain in place from the procedures first implemented during the 2025 lapse in appropriations. Each one alters something fundamental about the process you have spent 12 weeks learning to navigate.

The first: the percent of applications discussed in most meetings will remain at 30–35%, reduced from the usual approximately 50%.

The second: applications voted by the committee into the middle third will be designated "competitive but not discussed." Applications in the lowest third will be designated "not competitive and not discussed." Applications in the middle third will still be considered for funding alongside the discussed applications.

The third: summary statements will be simplified. Narrative paragraphs summarizing committee discussion will not be used. Summaries will instead contain a sentence describing the degree of consensus in the committee vote, plus bullets listing the main score-driving points. The written critiques from the three assigned reviewers will still appear. Discussed applications will still receive an overall impact score.

You read those changes in April and understood them as procedural. Now let me tell you what they mean.

When the room gets smaller

Discussion is not a formality. It is the mechanism through which individual reviewer positions get tested, challenged, and refined into a collective assessment. When an application is discussed, the room can surface disagreements. A reviewer who scored high can explain what they saw that the others missed. A reviewer who scored low can be asked to articulate whether their concern is structural or addressable. Someone who was not an assigned reviewer can raise a question that reframes the entire conversation.

I have sat in those rooms. I have watched a discussion shift an application's trajectory in three minutes - not because new information appeared, but because a single question forced the panel to distinguish between a real limitation and an assumed one.

When an application is discussed, the final score reflects a deliberation. When it is not discussed, the score reflects an aggregation. Those are not the same thing.

For the top third of applications - the ones that will still be discussed - everything I have taught you in this series still applies. The reviewers still write scripts. The room still deliberates. The Resume and Summary of Discussion, even in its simplified form, still captures something about where the panel landed. The framework holds.

For the remaining roughly two-thirds, the room does not convene. The written critiques and the committee vote are all that exist. And that changes the reading in ways that matter for your resubmission.

The split that changes what "not discussed" means

Under the traditional process, "not discussed" meant one thing: triaged. Bottom half. The panel decided the application did not warrant the investment of discussion time. It was a painful signal, but it was clear.

That clarity is gone.

Now "not discussed" splits into two categories with fundamentally different implications. "Competitive but not discussed" means the committee voted your application into the middle third - strong enough to remain in consideration for funding, but not prioritized for the limited discussion slots. "Not competitive and not discussed" means what "not discussed" used to mean.

If you receive a "not discussed" designation on your next summary statement, the first thing you need to determine is which category you are in. One means your application has a path to funding without revision. The other means it does not. The emotional difference between those two realities is enormous. The strategic difference is even larger.

For applicants in the "competitive but not discussed" category, the question is no longer "what went wrong" but "what would it take to move from the middle third into the top third on a resubmission -- or whether funding may come without one." That is a different kind of strategic calculation, and it requires reading your individual reviewer critiques with a different lens than someone whose application was designated not competitive.

The change that hits this series hardest

Narrative paragraphs summarizing committee discussion will not be used.

Read that again through the lens of the last two weeks.

In Week 11, I asked you to go back to your summary statement and find the sentence — the one in the Resume and Summary of Discussion where the room's actual concern crystallizes. The sentence that captures not what any individual reviewer wrote, but what the panel converged on after the scripts were performed, after the questions were asked, after someone across the table said "I actually didn't have that concern."

In Week 12, I told you to build your Introduction page around that sentence. To open with the room's voice. To show the new reviewer that you understood the structural issue, not just the individual critique points.

That sentence lived in a narrative paragraph. And narrative paragraphs are, for now, not being written.

What replaces them is a sentence describing the degree of consensus in the committee vote, plus bullets listing the main score-driving points.

A narrative R&SD could tell you: "The panel questioned whether the proposed recruitment strategy could achieve the projected sample size given the population's documented screening avoidance." That sentence gives you the room's specific concern. It gives you your resubmission brief.

A bullet that says "Recruitment feasibility" gives you the topic. It does not give you the room's concern within that topic. It does not tell you what the deliberation surfaced. It does not give you the sentence.

What this means for how you read your next summary statement

The framework I have been building in this series is not obsolete. It is more necessary - because you now have to do the interpretive work that the narrative R&SD used to do for you.

If your application was discussed and you receive a simplified summary statement, you will have three sources of information: the individual critiques from the three assigned reviewers, a consensus sentence, and score-driving bullets. The individual critiques still carry all the interpretive complexity I described in Weeks 10 and 11. They are still pre-discussion documents. They are still shaped by cognitive availability. They still give more words to concerns than strengths.

But now, instead of a narrative that tells you where the room landed, you have bullets that tell you what topics drove the score. The gap between those bullets and the room's actual reasoning is a gap you have to fill - by triangulating across the three reviewer critiques, identifying where they converge and diverge, and inferring the structural concern that likely animated the discussion.

This is harder. It requires more careful reading, not less. And it is exactly the kind of reading this series has been building you toward.

If your application was not discussed -- in either category -- you have only the individual critiques and the committee vote. There is no room to listen to. The reviewers' written positions are all that exist. In that case, the skill shifts entirely to reading across the three assigned critiques for convergence. Where do at least two of the three raise the same underlying concern, even if they articulate it differently? That convergence is the closest proxy you have for what the room would have said - because it is the pattern that would have emerged in discussion had discussion occurred.

What this means for how you write your next Introduction page

Everything I said last week still holds, but the source of your resubmission brief changes.

If you were discussed, look to the score-driving bullets and the consensus sentence - then triangulate against the individual critiques to find the specific concern underneath the topic label. Build your Introduction page around that concern, not around the bullet point. "Recruitment feasibility" is a category. Your Introduction page needs to answer the specific question within that category that drove the score.

If you were not discussed, your Introduction page must do something harder: demonstrate that you understood the convergent concern across the individual critiques even though no room ever named it for you. This requires more interpretive confidence, not less. And it is where the narrative Introduction page -- not the list -- becomes even more critical. Because the new reviewer reading your resubmission will be working from the same limited information you are. If your Introduction page can articulate the structural issue more clearly than the summary statement did, you have done something powerful: you have shown the new reviewer that you understood the assessment better than the format allowed it to be expressed.

That is not just responsiveness. That is intellectual leadership on the page.

What I want you to hold

These modifications are described as continuations of temporary adjustments. They may revert. They may not. But whether the format changes again next cycle is less important than the underlying principle: the amount of interpretive scaffolding you receive from a summary statement will vary. Sometimes you will get a narrative that hands you the room's concern in a sentence. Sometimes you will get bullets that give you a topic and nothing more. Sometimes there will be no discussion at all, and the only record of your review will be three individual critiques written before anyone in the room said a word.

In every case, the task is the same. Find the concern the room would have converged on - whether the room convened or not. Build your revision around it. Show the new reviewer that you understood what was fundamentally at issue.

The room got quieter. Your reading has to get sharper.

What is one piece of evaluative feedback you have received where the format made it harder, not easier, to understand what the evaluators actually thought?

Next week: the Specific Aims page. One page that every reviewer reads. One page that most applicants draft too late, revise too little, and mistake for a summary of their science when it is actually an argument for why their science matters now.

~Lisa Carter-Bawa, PhD, MPH, APRN, ANP-C, FAAN, FSBM

Lost In Translation (LIT) grantsmanship curriculum is available as an institutional cohort for cancer centers, training programs, and research-intensive departments.

The LIT Founders Cohort launched in August -- the first cohort outside of an institutional partnership -- and it was phenomenal.

Two seats remain for the next cohort — LIT February 2027 Deadline Cohort — and begins October 19 and is taking applications here. Five live Monday sessions, noon–1:30 PM ET, built around the Five Translation Gaps and timed so your Specific Aims page is reviewed, revised, and ready for the February 5 NIH deadline. The cohort includes full access to the LIT course (14 modules + 13 workbooks) plus a post-cohort Translation Feedback Brief — a one-on-one review of your revised Aims page and/or full grant returned in time for your submission.

10 seats. $997 includes the full LIT course and cohort experience. Already own the course? The cohort experience is $500. Apply here: https://forms.gle/5AWXyPwufN7LKSxr6

Future cohorts will be offered timed to the NIH grant submission cycle. If you would like to be placed on the waiting list for future cohorts, let me know here: https://forms.gle/Eysi8qEjBXNY1w388

Contact lisa@soultosoulleadership.com with any questions or visit lisacarterbawa.com/losttranslation to learn more.